Proactive Monitoring of Adalimumab Trough Concentration Associated With Increased Clinical Remission in Children With Crohn’s Disease Compared With Reactive Monitoring
Author:
Funder
AbbVie
Janssen
Pfizer
Ferring
Takeda
Biogen
Neopharm
Uniliver
Atlantic Health
Shire
Celgene
Lilly
Roche
AbbVie Pharmaceutical
Publisher
Elsevier BV
Subject
Gastroenterology,Hepatology
Reference35 articles.
1. Increased prevalence of anti-TNF therapy in paediatric inflammatory bowel disease is associated with a decline in surgical resections during childhood;Ashton;Aliment Pharmacol Ther,2019
2. Systematic review and network meta-analysis: first- and second-line biologic therapies for moderate-severe Crohn's disease;Singh;Aliment Pharmacol Ther,2018
3. Efficacy and safety of adalimumab for paediatric Crohn's disease: a systematic review;Dziechciarz;J Crohns Colitis,2016
4. Long-term efficacy and safety of adalimumab in pediatric patients with Crohn's disease;Faubion;Inflamm Bowel Dis,2017
5. Long-term outcome of tumor necrosis factor alpha antagonist's treatment in pediatric Crohn's disease;Assa;J Crohns Colitis,2013
Cited by 201 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. How comparative studies can inform treatment decisions for Crohn’s disease;Expert Opinion on Biological Therapy;2024-08-12
2. Real-world Clinical Effectiveness and Safety of Vedolizumab and Adalimumab in Biologic-naive Patients With Crohn’s Disease;Journal of Clinical Gastroenterology;2024-08-02
3. Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version 4.1) – living guideline;Zeitschrift für Gastroenterologie;2024-08
4. Model-informed precision dosing: State of the art and future perspectives;Advanced Drug Delivery Reviews;2024-08
5. Different infliximab induction dosing regimens do not affect remission rates up to 1 year in children with Crohn's disease;Journal of Pediatric Gastroenterology and Nutrition;2024-07-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3